FDA Approval of Cardiac Implantable Electronic Devices via Original and Supplement Premarket Approval Pathways, 1979-2012-Reference-Cited by-同舟云学术

FDA Approval of Cardiac Implantable Electronic Devices via Original and Supplement Premarket Approval Pathways, 1979-2012

Published:2014-01-22 Issue:4 Volume:311 Page:385
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Rome Benjamin N.¹,Kramer Daniel B.²,Kesselheim Aaron S.¹

Affiliation:

1. Harvard Medical School, Boston, Massachusetts2Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts

2. Harvard Medical School, Boston, Massachusetts2Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts3Beth Israel Deaconess Medical C

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Recall for Total Joint Arthroplasty Devices Over 10 Years;The Journal of Arthroplasty;2023-08

2. Medical Device Modifications Through Premarket Approval Supplements—Ensuring Patient Safety;JAMA Network Open;2023-04-12

3. Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements;JAMA Network Open;2023-04-12

4. Development of a conceptual framework for reporting modifications in surgical innovation: scoping review;BJS Open;2023-03-07

5. The FDA and Ensuring Safety and Effectiveness of Devices, Biologics, and Technology;Journal of the American Academy of Orthopaedic Surgeons;2022-06-02